Fibrinogen concentrate versus placebo for treatment of postpartum haemorrhage: a multicentre, prospective, double blind randomised controlled trial

Trial Profile

Fibrinogen concentrate versus placebo for treatment of postpartum haemorrhage: a multicentre, prospective, double blind randomised controlled trial

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 31 Jul 2017

At a glance

  • Drugs Fibrinogen (Primary)
  • Indications Postpartum haemorrhage
  • Focus Therapeutic Use
  • Acronyms OBS2
  • Most Recent Events

    • 31 Jul 2017 This trial has been completed in UK (on 2015-11-26) , according to European Clinical Trials Database.
    • 22 Feb 2016 Accrual to date is 148% according to the United Kingdom Clinical Research Network record.
    • 20 Feb 2016 Status changed from recruiting to active, no longer recruiting as reported by United Kingdom Clinical Research Network record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top